Thermo Fisher Scientific Contract Assets, Non-Current remained flat by 0.0% to $1.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 75.0%, from $4.00M to $1.00M. Over 5 years (FY 2020 to FY 2025), Contract Assets, Non-Current shows a downward trend with a -38.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests strong long-term project pipelines, while a decrease may indicate project completion or billing milestones being met.
Contract assets represent the company's right to consideration for services already performed that are not yet billed be...
Typical for firms with long-term service contracts; peers in project management will show higher levels.
contract_assets_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.00M | $11.00M | $9.00M | $11.00M | $10.00M | $9.00M | $7.00M | $8.00M | $6.00M | $5.00M | $4.00M | $9.00M | $7.00M | $8.00M | $6.00M | $4.00M | $1.00M | $1.00M | $1.00M | $1.00M |
| QoQ Change | — | +37.5% | -18.2% | +22.2% | -9.1% | -10.0% | -22.2% | +14.3% | -25.0% | -16.7% | -20.0% | +125.0% | -22.2% | +14.3% | -25.0% | -33.3% | -75.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +25.0% | -18.2% | -22.2% | -27.3% | -40.0% | -44.4% | -42.9% | +12.5% | +16.7% | +60.0% | +50.0% | -55.6% | -85.7% | -87.5% | -83.3% | -75.0% |